Zevin Asset Management’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.5M Buy
+63,310
New +$12.2M 1.73% 26
2025
Q4
Sell
-71,673
Closed -$11M 99
2025
Q3
$11M Sell
71,673
-3,997
-5% -$605K 1.6% 26
2025
Q2
$10.6M Buy
75,670
+1,577
+2% +$221K 1.52% 29
2025
Q1
$10.9M Sell
74,093
-2,345
-3% -$339K 1.73% 27
2024
Q4
$10M Buy
76,438
+9,388
+14% +$1.31M 1.47% 31
2024
Q3
$10.4M Sell
67,050
-378
-0.6% -$61K 1.62% 27
2024
Q2
$10.5M Buy
67,428
+648
+1% +$97.5K 1.7% 26
2024
Q1
$9.05M Buy
66,780
+1,897
+3% +$251K 1.51% 28
2023
Q4
$8.74M Buy
64,883
+1,608
+3% +$209K 1.57% 26
2023
Q3
$8.57M Buy
63,275
+1,787
+3% +$244K 1.72% 25
2023
Q2
$8.8M Buy
61,488
+191
+0.3% +$28.1K 1.77% 26
2023
Q1
$8.51M Buy
61,297
+8,953
+17% +$1.2M 1.74% 26
2022
Q4
$7.1M Buy
+52,344
New +$6.56M 1.54% 30

Other funds holding AZN